We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

Summit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation ...

We recently compiled a list of the 10 Hot Growth Stocks to Invest in According to Analysts. In this article, we are going to ...

Summit Therapeutics (NASDAQ:SMMT – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” ...

Deep-pocketed investors have adopted a bullish approach towards Summit Therapeutics (NASDAQ:SMMT), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is a biopharmaceutical company focused on developing innovative medicines for infectious diseases and oncology. Its pipeline includes targeted therapies ...

In a report released today, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Summit Therapeutics (SMMT – Research Report), with a ...

Rhumbline Advisers raised its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and ...

Principal Financial Group Inc. boosted its stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 252.8% in the fourth quarter, HoldingsChannel.com reports.The fund owned ...

Equities researchers at The Goldman Sachs Group initiated coverage on shares of Summit Therapeutics (NASDAQ:SMMT – Get Free Report) in a report released on Friday, Marketbeat.com reports.

New York State Common Retirement Fund increased its stake in Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 18.6% in the fourth quarter, Holdings Channel.com reports. The institutional ...

In this article, we are going to take a look at where Summit Therapeutics Inc. (NASDAQ:SMMT) stands against the other hot growth stocks. The big rally in the broader stock market might have ceased ...